Heavy Dosage of Vitamin D Might Help Ward Off Skin Cancer

.

Heavy Dosage of Vitamin D Might Help Ward Off Skin Cancer

Recent researches at Henry Ford and Wayne State University have thrown light on relation between Vitamin D levels and basal cell carcinoma.

Dr. Lappe, a Professor at Creighton University in Nebraska, and the Lead Researcher says the study will entail 2,300 postmenopausal women. They will be observed for four years to see if the vitamin reduces cancer rates, along with the incidence of heart disease and diabetes.

Another study, in which 20,000 people will be involved, will check if fish oils are good for heart health and stroke prevention. It is scheduled to go on for almost seven years.

U. S. National Institutes of Health are sponsoring both studies.

Studies have also found that people living at northern latitudes are more prone to cancer, diabetes, and other chronic ailments, compared with those who living further south.

The concept that vitamin deficiency might lead to cancer and many other illnesses has given way to debates among medical research community. Physicians are of the belief that effectiveness and probable side effects should be ascertained before people start taking them in bulk.


Latest News

Mt. Gox Bitcoin Head Arrested on Sunday for Suspected Misuse of Bitcoins
Consortium of German Automakers Acquiring HERE Map Business from Nokia
HSBC Holdings Plc Agrees to Sell It’s Brazil unit to Bradesco for $5.2 Billion
Fourth Corner Credit Union’s Bid for Permission to go Into Business Rejected
Nebraska Gov. Ricketts and Lt. Gov. Foley to Traveling to Japan in Trade Mission
Fennica , the Icebreaker Leaves for Arctic Waters as Portland Police Remove Prot
PPIC’s Poll Reveals Californians Divided in Opinion on Climate Change Impacting
Chairman Says the Boeing Company May have to Move Some Operations Overseas if Ex
Facebook Second Quarter Earnings Surpass Analysts’ Expectations but Growing Expe
Overcharging Scandal Takes a Toll on Whole Foods Earnings
Yelp Trims Third Quarter Earnings Forecast Also Announces Departure of Its Chair
Solvay, the Belgian Chemical Group to Acquire U.S. Cytec for $5.5 billion